Theglobeandmail
Published October 9, 2026 · Updated October 10, 2026
BetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha
Read the full story at Theglobeandmail
BETR-001 is a non-hallucinogenic derivative of 2-bromo-lysergic acid diethylamide (2-Br- LSD ) in development for the preventive treatment of.
Surfaced by this Google Alert
- LSD